|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
ELV035342161 |
| 003 |
DE-627 |
| 005 |
20230624021908.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
180603s2016 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.earlhumdev.2016.05.008
|2 doi
|
| 028 |
5 |
2 |
|a GBVA2016012000020.pica
|
| 035 |
|
|
|a (DE-627)ELV035342161
|
| 035 |
|
|
|a (ELSEVIER)S0378-3782(16)30031-7
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 082 |
0 |
|
|a 610
|
| 082 |
0 |
4 |
|a 610
|q DE-600
|
| 082 |
0 |
4 |
|a 618.3/005
|q OCLC
|
| 082 |
0 |
4 |
|a 610
|q VZ
|
| 082 |
0 |
4 |
|a 610
|q VZ
|
| 084 |
|
|
|a 44.45
|2 bkl
|
| 100 |
1 |
|
|a Seggers, Jorien
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Neonatal fatty acid status and cardiometabolic health at 9years
|
| 264 |
|
1 |
|c 2016
|
| 300 |
|
|
|a 5
|
| 336 |
|
|
|a nicht spezifiziert
|b zzz
|2 rdacontent
|
| 337 |
|
|
|a nicht spezifiziert
|b z
|2 rdamedia
|
| 338 |
|
|
|a nicht spezifiziert
|b zu
|2 rdacarrier
|
| 520 |
|
|
|a Long chain polyunsaturated fatty acid (LCPUFA) status is associated with risk of cardiovascular diseases in adulthood. We previously demonstrated no effect of LCPUFA supplementation after birth on BP and anthropometrics. Little is known about the association between fatty acid status at birth and cardiometabolic health at older ages.
|
| 700 |
1 |
|
|a Kikkert, Hedwig K.
|4 oth
|
| 700 |
1 |
|
|a de Jong, Corina
|4 oth
|
| 700 |
1 |
|
|a Decsi, Tamas
|4 oth
|
| 700 |
1 |
|
|a Boehm, Gunther
|4 oth
|
| 700 |
1 |
|
|a Hadders-Algra, Mijna
|4 oth
|
| 773 |
0 |
8 |
|i Enthalten in
|n Elsevier Science
|a Abdel-Aziz, Tarek Ezzat ELSEVIER
|t Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics
|d 2014
|g Amsterdam [u.a.]
|w (DE-627)ELV022803173
|
| 773 |
1 |
8 |
|g volume:100
|g year:2016
|g pages:55-59
|g extent:5
|
| 856 |
4 |
0 |
|u https://doi.org/10.1016/j.earlhumdev.2016.05.008
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_U
|
| 912 |
|
|
|a GBV_ELV
|
| 912 |
|
|
|a SYSFLAG_U
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a GBV_ILN_130
|
| 912 |
|
|
|a GBV_ILN_350
|
| 936 |
b |
k |
|a 44.45
|j Immunologie
|q VZ
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 100
|j 2016
|h 55-59
|g 5
|
| 953 |
|
|
|2 045F
|a 610
|